Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014437-24Phase 3Active
Phase 3, randomised trial in critical illness and Healthcare-associated infection (HAI) comparing L-arginine immunonutrition with Placebo (2 arms). Primary endpoints: Nasal nitric oxide concentration, Monocyte HLA-DR expression and 5 more. Started Aug 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014437-24.